Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label pediatric epilepsy adjunctive perampanel trial
2018-004456-38Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perampanel in epilepsy, Focal onset seizure and epilepsy syndrome, sponsored by Eisai Co., Ltd. Primary endpoint: Proportion of 50% responders for all seizures. Started Jul 2019; status: terminated.
02
Drugs
perampanel
03
Conditions
epilepsyFocal onset seizureepilepsy syndrome
Beyond the preview
Go deeper on 2018-004456-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004456-38.